Genesco Inc. secured unanimous endorsement from the three independent proxy advisory firms that matter—ISS, Glass Lewis, and Egan-Jones—ahead of its annual meeting Tuesday, where shareholders re-elected all nine incumbent directors and closed the door on activist Bradley Radoff's challenge. The footwear retailer, trading at $1.4 billion market cap, now operates without the distraction of a board contest for the first time in eight months.
Radoff had been pressing for board representation since last summer, arguing the Nashville-based company underperformed peers in comparable-store sales growth and margin expansion. He wanted two seats. The proxy firms disagreed. ISS cited management's 12-month turnaround in gross margin and inventory discipline. Glass Lewis pointed to the board's refresh over the past 18 months—three new independent directors, all with retail operations experience. Egan-Jones noted that Genesco's stock had outperformed the S&P Retail Select Sector Index by 780 basis points since Radoff's public campaign began in June. Shareholders voted accordingly.
The advisory convergence is unusual in fights where the activist controls a meaningful stake but lacks institutional co-investors. Radoff held roughly 4.7% of shares outstanding through various entities. That is typically enough to force at least a negotiated settlement or one board seat. But Genesco's recent operational tightening—gross margin up 210 basis points year-over-year in the most recent quarter, inventory down 11%—gave the advisors numerical cover to back continuity. The company also preempted governance criticism by separating the CEO and Chairman roles in Q3 2024 and adding a retail veteran with prior turnaround experience at a $900 million apparel chain. Radoff had no second-order capital behind him, no public letters from other large holders, and no clear thesis beyond "underperformance" that the trailing numbers no longer supported.
What matters now is whether Genesco can sustain the margin discipline that kept the board intact. The company operates 1,425 stores across Journeys, Johnston & Murphy, and Schuh, with 57% of revenue still tied to mall-based footwear. Comparable-store sales turned positive in Q4 2024 after five quarters of declines, but spring selling season will test whether that momentum holds. Management guides to $50-$55 million in free cash flow for fiscal 2026, implying 3.6-3.9% yield at current valuation. The board now has 12 months of runway without proxy noise to prove the margin gains are structural, not cyclical. If gross margin slips below 48% or inventory rebuilds faster than sales, expect Radoff or a similar holder to surface again before the 2026 proxy season.
The vote also signals that proxy advisors will tolerate a narrow operational thesis from activists only when the numbers are deteriorating in real time. Genesco's inventory and margin fixes came fast enough to erase the case for disruption. Radoff exits with no board influence and no apparent path to force a sale or breakup, which leaves the incumbents accountable for the next four quarters of execution without the excuse of distraction.